GeoVax Labs (GOVX) Total Liabilities (2010 - 2026)
GeoVax Labs (GOVX) posted quarterly Total Liabilities of $2.9 million for Q2 2026, down 46.13% year-over-year from $5.4 million in Q2 2025, and up 14.52% quarter-over-quarter from $2.5 million in Q4 2025.
GeoVax Labs (GOVX) Total Liabilities (2010 - 2026) Analysis & Trends
GeoVax Labs (GOVX) has reported Total Liabilities for 17 consecutive years, with $2.9 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Total Liabilities fell 46.13% year-over-year to $2.9 million; the TTM figure through Jun 2026 stood at $2.9 million (down 46.13% YoY), while the FY2025 annual figure was $2.5 million, down 19.01% from the prior year.
- Total Liabilities grew to $2.9 million in Q2 2026 per GOVX's latest filing, from $2.5 million in the prior quarter.
- Across five years, Total Liabilities topped out at $27.4 million in Q1 2023 and bottomed at $2.5 million in Q4 2025.
- Historically, Total Liabilities has averaged $8.6 million across 5 years, with a median of $5.5 million in 2022.
- Annual changes were most pronounced in 2022 — Total Liabilities jumped 1922.76% — and 2024, when it plunged 87.75%.
- GeoVax Labs' Total Liabilities stood at $4.7 million in 2022, then surged by 95.52% to $9.3 million in 2023, then sank by 66.53% to $3.1 million in 2024, then retreated by 19.01% to $2.5 million in 2025, then increased by 14.52% to $2.9 million in 2026.
- Business Quant data shows GOVX's Total Liabilities at $2.9 million in Q2 2026, $2.5 million in Q4 2025, and $6.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.20 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 3.22 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.35 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 10.03 Bn |
| 10 | GeoVax Labs | 2.88 Mn | -260,493.75 | - | 2.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.88 Mn |
| Dec 31, 2025 | 2.52 Mn |
| Sep 30, 2025 | 6.73 Mn |
| Jun 30, 2025 | 5.35 Mn |
| Mar 31, 2025 | 10.83 Mn |
| Dec 31, 2024 | 3.11 Mn |
| Sep 30, 2024 | 11.11 Mn |
| Jun 30, 2024 | 4.10 Mn |
| Mar 31, 2024 | 3.36 Mn |
| Dec 31, 2023 | 9.28 Mn |
| Sep 30, 2023 | 16.20 Mn |
| Jun 30, 2023 | 21.25 Mn |
| Mar 31, 2023 | 27.40 Mn |
| Dec 31, 2022 | 4.75 Mn |
| Sep 30, 2022 | 6.79 Mn |
| Jun 30, 2022 | 5.37 Mn |
| Mar 31, 2022 | 5.50 Mn |
| Dec 31, 2021 | 7.44 Mn |
| Sep 30, 2021 | 335,650.00 |
| Jun 30, 2021 | 359,022.00 |